Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP27620.RAsJQc2oRtOisA6ZjfC5hnOsHm-MjsdnzZyz6OAOidWVE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP27620.RAsJQc2oRtOisA6ZjfC5hnOsHm-MjsdnzZyz6OAOidWVE130_assertion type Assertion NP27620.RAsJQc2oRtOisA6ZjfC5hnOsHm-MjsdnzZyz6OAOidWVE130_head.
- NP27620.RAsJQc2oRtOisA6ZjfC5hnOsHm-MjsdnzZyz6OAOidWVE130_assertion description "[These novel findings may provide an important molecular framework for further evaluation of selective inhibition of EP2 and EP4 as potential therapy, including nonestrogen target, to expand the spectrum of currently available treatment options for endometriosis in women.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27620.RAsJQc2oRtOisA6ZjfC5hnOsHm-MjsdnzZyz6OAOidWVE130_provenance.
- NP27620.RAsJQc2oRtOisA6ZjfC5hnOsHm-MjsdnzZyz6OAOidWVE130_assertion evidence source_evidence_curated NP27620.RAsJQc2oRtOisA6ZjfC5hnOsHm-MjsdnzZyz6OAOidWVE130_provenance.
- NP27620.RAsJQc2oRtOisA6ZjfC5hnOsHm-MjsdnzZyz6OAOidWVE130_assertion SIO_000772 19407222 NP27620.RAsJQc2oRtOisA6ZjfC5hnOsHm-MjsdnzZyz6OAOidWVE130_provenance.
- NP27620.RAsJQc2oRtOisA6ZjfC5hnOsHm-MjsdnzZyz6OAOidWVE130_assertion wasDerivedFrom ctd_human-20130708 NP27620.RAsJQc2oRtOisA6ZjfC5hnOsHm-MjsdnzZyz6OAOidWVE130_provenance.
- NP27620.RAsJQc2oRtOisA6ZjfC5hnOsHm-MjsdnzZyz6OAOidWVE130_assertion wasGeneratedBy ECO_0000218 NP27620.RAsJQc2oRtOisA6ZjfC5hnOsHm-MjsdnzZyz6OAOidWVE130_provenance.